Vanderbilt researchers have received a $2.15 million grant to study the amount and activity of “brown fat” in adults, with the aim of understanding its role in metabolic disease and identifying new therapeutic targets.

A Vanderbilt University-led research team has discovered a molecular “rheostat” in the brain’s appetite control center that may provide new insights into obesity, which is at epidemic levels in this country.

An overactive stress response contributes to the development of insulin resistance in obese individuals, and blocking it may be therapeutically beneficial.

Vanderbilt University researchers are closer to understanding the link between obesity, chronic inflammation and type 2 diabetes.

Chancellor Nicholas S. Zeppos, Provost Susan Wente and several Vanderbilt experts joined colleagues from across the Southeast to discuss obesity at the second annual Southeastern Conference Symposium Sept. 21-23.

Early weight regain after gastric bypass surgery does not reverse metabolic improvements, and the "hunger hormone" ghrelin might indicate who is susceptible to weight regain.

Engineered bacteria that produce a therapeutic compound in the gut prevent obesity in mice, Vanderbilt University investigators have discovered.